Parker Institute For Cancer Immunotherapy

Parker Institute For Cancer Immunotherapy Overview

Parker Institute For Cancer Immunotherapy is located in San Francisco, CA. The organization was established in 2015. According to its NTEE Classification (E12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Health Care and related organizations. As of 12/2019, Parker Institute For Cancer Immunotherapy employed 88 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations.

For the year ending 12/2019, Parker Institute For Cancer Immunotherapy generated $162.6m in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 17.2% each year . All expenses for the organization totaled $78.0m during the year ending 12/2019. While expenses have increased by 2.4% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Since 2015, Parker Institute For Cancer Immunotherapy has awarded 56 individual grants totaling $185,874,997. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2019

Describe the Organization's Mission:

Part 3 - Line 1

THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) WAS CREATED TO ENCOURAGE ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH AND TO HELP REDUCE OBSTACLES TO COLLABORATION, DISCOVERY AND TRANSLATION OF THESE ADVANCES FOR PATIENTS. PICI ACHIEVES THIS GOAL BY FUNDING A CONSORTIUM OF PREEMINENT ACADEMIC AND MEDICAL RESEARCH INSTITUTIONS WHICH WORK COLLABORATIVELY ON RESEARCH IN THE FIELD OF CANCER IMMUNOTHERAPY. IN ADDITION, PICI FURTHERS ITS CHARITABLE PURPOSES BY EMPLOYING ITS OWN PERSONNEL TO DIRECTLY CONDUCT RESEARCH AND CLINICAL TRIALS.

Describe the Organization's Program Activity:

Part 3 - Line 4a

PICI ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI CONDUCTS ITS OWN RESEARCH AND CLINICAL TRIALS AND PROVIDES ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.


Do You Work With Nonprofits?Intellispect helps service providers identify nonprofit prospects and make contact with decision makers.

Parker Institute For Cancer Immunotherapy Vendors

Vendor Name (Service)Compensation
Precision Cancer Research
Biostorage And Sample Processing
$1,562,828
Clinlogix
Clinical Trial Monitoring
$726,294
Greenphire
Clinical Trial Payment Processing
$1,074,374
Biostorage Technologies Inc
Biostorage And Sample Processing
$972,929
Aris Clinical Inc
Clinical Trial Monitoring
$1,340,873
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$146,644,584
Noncash contributions included in lines 1a–1f $50,092,869
Total Revenue from Contributions, Gifts, Grants & Similar$146,644,584
Total Program Service Revenue$15,232,654
Investment income $771,326
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $162,648,564

Parker Institute For Cancer Immunotherapy Grants Awarded

Over the last fiscal year, Parker Institute For Cancer Immunotherapy has awarded $34,385,416 in support to 13 organizations.

Grant RecipientAmount

UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$10,042,040

REGENTS OF UNIVERSITY OF CALIFORNIA SAN FRANCISCO

Org PageRecipient Profile

San Francisco, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$5,593,452

UNIVERSITY OF PENNSYLVANIA

Org PageRecipient Profile

Philadelphia, PA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$5,452,600

MEMORIAL SLOAN KETTERING CANCER CENTER

Org PageRecipient Profile

New York, NY

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$4,352,647

STANFORD UNIVERSITY

Org PageRecipient Profile

Redwood City, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$2,425,569

UNIVERSITY OF CALIFORNIA LOS ANGELES

Org PageRecipient Profile

Los Angeles, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$2,260,431
View Grant Profile

Parker Institute For Cancer Immunotherapy Grants Recieved

Over the last fiscal year, we have identified 1 grants that Parker Institute For Cancer Immunotherapy has recieved totaling $397,293.

Awarding OrganizationAmount
Jdrf International

New York, NY

PURPOSE: IMMUNOTHERAPIES

$397,293
View Grant Recipient Profile

Create a Free Account

Create an account to unlock the data you need.

or
I